AI assistant
Sending…
Ovid Therapeutics Inc. — Director's Dealing 2021
Jun 12, 2021
34195_dirs_2021-06-11_b01c9509-5b3a-42a9-ac67-383334f05810.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ovid Therapeutics Inc. (OVID)
CIK: 0001636651
Period of Report: 2021-06-11
Reporting Person: Friedman Bart (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-11 | Stock Option (Right to Buy) | $4.49 | A | 15000 | Acquired | 2031-06-10 | Common Stock (15000) | Direct |
Footnotes
F1: The option will vest in full on June 11, 2022 subject to the Reporting Person's continuous service through such vesting date.
More from Ovid Therapeutics Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 26
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2